Niioka Takenori

ニイオカタケノリ | Niioka Takenori

Affiliation and department：
Job title： Professor

Research field (1)： Clinical pharmacy

Research keywords (2)： Clinical pharmacokinetics , Clinical pharmacology

Research theme for competitive and other funds (9)：

2023 - 2027 人工知能を活用した津軽弁から共通語への音声・文字情報変換システムの基盤技術開発
2021 - 2024 Individualization of oral hypoxia-inducible factor prolyl hydroxylase inhibitor dosage based on gene polymorphisms related to drug responsiveness
2018 - 2022 Effects of C-reactive protein and nuclear receptors on pharmacokinetics of voriconazole
2015 - 2018 Influence of tacrolimus initial doing strategy based on the CYP3A5 polymorphisms on quantitative interstitial fibrosis, rejection rate, and long-term graft function in kidney transplant recipients.
2014 - 2018 Do patients taking tacrolimus need to undergo CYP3A5 genotyping along with blood concentration monitoring?

Show all

Papers (91)：

Kazuyuki Numakura, Ryoma Igarashi, Makoto Takahashi, Taketoshi Nara, Sohei Kanda, Mitsuru Saito, Shintaro Narita, Takamitsu Inoue, Takenori Niioka, Masatomo Miura, et al. Influence of genetic polymorphisms in vascular endothelial-related genes on the clinical outcome of axitinib in patients with metastatic renal cell carcinoma. Cancer biology & therapy. 2024. 25. 1. 2312602-2312602
Taishu Kanda, Taiichi Wakiya, Keinosuke Ishido, Norihisa Kimura, Hayato Nagase, Eri Yoshida, Junichi Nakagawa, Masashi Matsuzaka, Takenori Niioka, Yoshihiro Sasaki, et al. Noninvasive Computed Tomography-Based Deep Learning Model Predicts In Vitro Chemosensitivity Assay Results in Pancreatic Cancer. Pancreas. 2024
Junichi Nakagawa, Takenori Takahata, Yu Chen, Kensuke Saito, Kosuke Kamata, Takuto Tachita, Satoru Yamashita, Keigo Saito, Kayo Ueno, Atsushi Sato, et al. Influence of CYP3A5 and ABCB1 polymorphisms on the pharmacokinetics of vincristine in adult patients receiving CHOP therapy. Cancer chemotherapy and pharmacology. 2023. 92. 5. 391-398
Junichi Nakagawa, Takahiko Kinjo, Naoya Aiuchi, Kayo Ueno, Hirofumi Tomita, Takenori Niioka. Associations among Plasma Concentrations of Edoxaban and M-4, Prothrombin Time, and the SLCO1B1*15 Haplotype in Patients With Nonvalvular Atrial Fibrillation. Therapeutic drug monitoring. 2023. 45. 3. 409-416
Junichi Nakagawa, Takahiko Kinjo, Naoya Aiuchi, Kayo Ueno, Hirofumi Tomita, Takenori Niioka. Effect of pregnane X receptor and cytochrome P450 oxidoreductase gene polymorphisms on trough concentrations of rivaroxaban and edoxaban in patients with nonvalvular atrial fibrillation. European journal of clinical pharmacology. 2023. 79. 5. 703-705

ｍore...

MISC (21)：

細井一広, 新岡丈典. 【最適治療を目指すなら、ここまで知っておきたい「がん×他領域」の最新知識】がん×消化器. 薬事. 2020. 62. 3. 537-543
新岡丈典. 【がん治療と薬物相互作用ピットフォールに陥らないための基礎と実践】がん患者の支持療法における薬物相互作用マネジメント発熱性好中球減少症. 薬局. 2019. 70. 7. 1452-1458
中川潤一, 石戸圭之輔, 東野優花, 木村憲央, 脇屋太一, 岡村祐嗣, 袴田健一, 新岡丈典. 生体肝移植術後早期におけるタクロリムス点滴持続静注時の母集団薬物動態解析. TDM研究. 2019. 36. 2. 167-167
新岡丈典. 【モニタリングから介入まで自信をもって対応できる薬物相互作用】抗凝固薬と抗菌薬・抗真菌薬との薬物相互作用. 薬事. 2019. 61. 4. 619-624
谷川原祐介, 増田智先, 上杉美和, 梶原望渡, 河崎陽一, 川尻雄大, 竹内裕紀, 内藤隆文, 布田伸一, 福土将秀, et al. 免疫抑制薬TDM標準化ガイドライン2018 臓器移植編 Executive Summary. TDM研究. 2019. 36. 1. 19-42

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page